Page 3 - டேனிஷ் ஆரோக்கியம் அதிகாரம் ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

South Africa halts AstraZeneca vaccine rollout AstraZeneca vaccine use in Europe A delivery of 1 million doses of the vaccine developed by the British-Swedish pharmaceutical company vaccine went to 17 EU countries. A lack of efficacy data on its use in people over 65 has led to several health authorities limiting its use.  Germany s independent Standing Committee on Vaccination (Stiko) recently approved the AstraZeneca for use in people of all ages after new data was released.  However, many AstraZeneca doses are going unused in Germany due to worries that the vaccine is less effective against virus mutations.  South Africa halted the rollout of the vaccine due to a trial showing it was less effective against the South African B.1.351 COVID variant.

United statesHong kongUnited kingdomNew zealandSouth koreaNew yorkSouth africaCity ofPoitou charentesSouth africanAngela merkelDonald trumpTedros adhanom ghebreyesusKim kyung hoonSoren brostromPolly roy